Solid Tumor Webinar 8/30/18 Q&A "IF THERE WERE A simple explanation of exactly what changed with each subsequent revision we would know if a simple edit vs printing the entire section is required. Is this possible?" We extend our apologies for the ongoing revisions to the final rules. Because the rules had to be coordinated with other major 2018 projects, the final project was delayed beyond our expectations. Priorities did not allow for beta testing prior to the release, and as a result, registrars using the rules are identifying issues which we will continue to correct. We understand the major impact this has had upon registrars and we appreciate your feedback. We will do everything within our control to communicate the importance and priority of the solid tumor rules. We also realize that it has been difficult to determine what changes have been made. Changes fall in two categories; Major changes which are posted in the change log. Major changes are those which would or could affect coding. From now on the change log will be as follows: Date of change Version 1.1 to Version 1.2 M3 Added Note 2 Minor changes which do not affect coding. When there is a revision date added with no change log entry, the change does not affect the rules or usage of the rules. Minor changes include Correcting a misspelled word Changing a word, such as: When preparing for this webinar, I noticed a preface which said there are major site groups. “two” The bullets correctly showed three site groups. The word “two” was changed to “three.” There were multiple questions regarding ambiguous terminology: Can you talk about using ambiguous terms please? ex: breast malignancy consistent with ductal carcinoma (see bi1); lung bx non-small cell carcinoma consistent with adenocarcinoma (see ii1): colon consistent with adenocarcinoma- thanks Regarding ambiguous terminology, it's not a matter of a pathologist diagnosing only as, "consistent with adenocarcinoma." Pathologists frequently diagnose tumors ambiguous terminology and we are missing out on specific histologies. Here are several common examples we see: "non-small cell carcinoma, most consistent with squamous cell carcinoma, (see ii1)" or
Solid Tumor Webinar 8/30/18 Q&A "IF THERE WERE A simple explanation of exactly what changed with each subsequent revision we would know if a simple edit vs printing the entire section is required. Is this possible?" We extend our apologies for the ongoing revisions to the final rules. Because the rules had to be coordinated with other major 2018 projects, the final project was delayed beyond our expectations. Priorities did not allow for beta testing prior to the release, and as a result, registrars using the rules are identifying issues which we will continue to correct. We understand the major impact this has had upon registrars and we appreciate your feedback. We will do everything within our control to communicate the importance and priority of the solid tumor rules. We also realize that it has been difficult to determine what changes have been made. Changes fall in two categories; Major changes which are posted in the change log. Major changes are those which would or could affect coding. From now on the change log will be as follows: Date of change Version 1.1 to Version 1.2 M3 Added Note 2 Minor changes which do not affect coding. When there is a revision date added with no change log entry, the change does not affect the rules or usage of the rules. Minor changes include Correcting a misspelled word Changing a word, such as: When preparing for this webinar, I noticed a preface which said there are “two” major site groups. The bullets correctly showed three site groups. The word “two” was changed to “three.” There were multiple questions regarding ambiguous terminology: Can you talk about using ambiguous terms please? ex: breast malignancy consistent with ductal carcinoma (see bi1); lung bx non-small cell carcinoma consistent with adenocarcinoma (see ii1): colon consistent with adenocarcinoma- thanks Regarding ambiguous terminology, it's not a matter of a pathologist diagnosing only as, "consistent with adenocarcinoma." Pathologists frequently diagnose tumors ambiguous terminology and we are missing out on specific histologies. Here are several common examples we see: "non-small cell carcinoma, most consistent with squamous cell carcinoma, (see ii1)" or
naaccr_d9f95039af883046461d048d0501e158.docx